Prostate cancer management is evolving rapidly. This episode explores the cutting-edge advancements transforming diagnosis and treatment. From the precise ISUP Grade Group System and essential multi-parametric MRI, to personalized strategies like active surveillance for low-risk disease, we cover it all. Discover the impact of triplet therapy for metastatic cases, targeted radiotherapy, refined approaches for biochemical recurrence, and the breakthrough Lutetium-177 PSMA therapy for advanced prostate cancer. Stay informed on the latest standards enhancing patient outcomes.


Source: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02221-4/abstract


Subscribe to our Substack: https://substack.com/@rokeefemd

Rss
Podden och tillhörande omslagsbild på den här sidan tillhör Point of Care Medicine. Innehållet i podden är skapat av Point of Care Medicine och inte av, eller tillsammans med, Poddtoppen.